Literature DB >> 8377240

Multiple organ dysfunction after mesenteric artery revascularization.

T R Harward1, D L Brooks, T C Flynn, J M Seeger.   

Abstract

PURPOSE: Mesenteric arterial reconstruction in patients with acute or chronic intestinal ischemia is associated with significant morbidity and mortality rates. Reperfusion of ischemic bowel in animals leads to release of multiple factors that cause organ dysfunction. Similar phenomena potentially occur in human beings after repair of symptomatic chronic mesenteric arterial disease. The purpose of this study was to define the incidence of multiple organ dysfunction seen after reperfusion of the chronically ischemic bowel.
METHOD: Between January 1990 and January 1993, 18 patients underwent surgical revascularization for symptomatic chronic mesenteric arterial occlusive disease. Four patients required emergency surgery, whereas 14 procedures were done electively. Hepatic, renal, pulmonary, and coagulation function were evaluated in all patients. Bypass graft patency was confirmed by duplex scanning or repeat operation in all patients with deteriorating conditions.
RESULTS: Immediately after surgery hepatic function deteriorated. The serum transaminases increased 90- to 100-fold whereas lactate dehydrogenase increased 25-fold. Simultaneously, platelet counts dropped below 40,000 mm3 in 11 patients. On postoperative day 2, 16 patients had acute pulmonary insufficiency demonstrated by an increase in the pulmonary shunt fraction to a mean of 32% +/- 3% (range 21% to 60%). Ten patients required reintubation, and lung failure lasted an average of 8.4 days (range 1 to 35 days). Hepatic and coagulation function changes were usually transient, returning to baseline within 7 to 10 days. Four of the patients who had multiple organ dysfunction died (two after elective surgery), and one patient died of myocardial infarction after emergency surgery.
CONCLUSION: Revascularization of chronically ischemic bowel leads to significant multiple organ dysfunction, potentially as a result of intestinal ischemia and reperfusion injury.

Entities:  

Mesh:

Year:  1993        PMID: 8377240     DOI: 10.1067/mva.1993.48586

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  15 in total

1.  Intestinal ischemia and reperfusion impairs vasomotor functions of pulmonary vascular bed.

Authors:  C Köksoy; M A Kuzu; H Ergün; E Demirpençe; B Zülfikaroglu
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Vasopressin as adjunct vasopressor for vasodilatory shock due to non-occlusive mesenteric ischemia.

Authors:  G Luckner; S Jochberger; V D Mayr; H Knotzer; W Pajk; V Wenzel; B Friesenecker; I Lorenz; M W Dünser
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

Review 3.  Acute mesenteric ischemia after cardio-pulmonary bypass surgery.

Authors:  Bassam Abboud; Ronald Daher; Joe Boujaoude
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

4.  Gut Microbiota Restricts NETosis in Acute Mesenteric Ischemia-Reperfusion Injury.

Authors:  Stefanie Ascher; Eivor Wilms; Giulia Pontarollo; Henning Formes; Franziska Bayer; Maria Müller; Frano Malinarich; Alexandra Grill; Markus Bosmann; Mona Saffarzadeh; Inês Brandão; Kathrin Groß; Klytaimnistra Kiouptsi; Jens M Kittner; Karl J Lackner; Kerstin Jurk; Christoph Reinhardt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-07-02       Impact factor: 8.311

Review 5.  Procalcitonin and intestinal ischemia: a review of the literature.

Authors:  Cyril Cosse; Charles Sabbagh; Saïd Kamel; Antoine Galmiche; Jean-Marc Regimbeau
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

6.  Impact of intestinal ischemia/reperfusion and lymph drainage on distant organs in rats.

Authors:  Gui-Zhen He; Kai-Guo Zhou; Rui Zhang; Yu-Kang Wang; Xue-Feng Chen
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  Endovascular versus open revascularization for chronic mesenteric ischemia: a comparative study.

Authors:  P Zerbib; G Lebuffe; G Sergent-Baudson; A Chamatan; D Massouille; C Lions; J P Chambon
Journal:  Langenbecks Arch Surg       Date:  2008-06-25       Impact factor: 3.445

8.  Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.

Authors:  Lavinia M Proctor; Thiruma V Arumugam; Ian Shiels; Robert C Reid; David P Fairlie; Stephen M Taylor
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

9.  HGF/c-Met signaling mediated mesenchymal stem cell-induced liver recovery in intestinal ischemia reperfusion model.

Authors:  Jianpei Liu; Guozheng Pan; Tangzhao Liang; Pinjie Huang
Journal:  Int J Med Sci       Date:  2014-04-24       Impact factor: 3.738

10.  The protective effects of curcumin on experimental acute liver lesion induced by intestinal ischemia-reperfusion through inhibiting the pathway of NF-κB in a rat model.

Authors:  Zhe Fan; Huirong Jing; Jihong Yao; Yang Li; Xiaowei Hu; Huizhu Shao; Gang Shen; Jiyong Pan; Fuwen Luo; Xiaofeng Tian
Journal:  Oxid Med Cell Longev       Date:  2014-08-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.